MB-102
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MB-102, covering 2023-10-26 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium [EARLY_Phase 1]